InterventionsHuman trial

High-Dose Semaglutide Is Associated with Preservation of Kidney Function in People Living with Obesity without Diabetes

ADA Scientific Sessions 2026 Abstract

The paper

ROSSING P, JACOBSEN CSF, HJELMESÆTH J et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2700-LB

doi.org/10.2337/db26-2700-lb

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026